GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
18.49
+1.07 (6.14%)
Jan 21, 2025, 4:00 PM EST - Market closed
GRAIL Employees
GRAIL had 1,360 employees as of December 31, 2023.
Employees
1,360
Change
n/a
Growth
n/a
Revenue / Employee
$86,521
Profits / Employee
-$1,556,960
Market Cap
621.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
GRAL News
- 8 days ago - Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology - PRNewsWire
- 4 weeks ago - GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 6 weeks ago - World's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumbles - Market Watch
- 7 weeks ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - GRAIL to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study - PRNewsWire
- 2 months ago - GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - GRAIL Reports Third Quarter 2024 Financial Results - PRNewsWire